EDRH
MRTX

Edmond de Rothschild Holding’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Edmond de Rothschild Holding’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-184,060
Closed -$6.65M – 751
2023
Q2 		$6.65M Hold
184,060
– – 0.13% 147
2023
Q1 		$6.84M Buy
184,060
+15,000
+9% +$675K 0.16% 141
2022
Q4 		$7.66M Buy
169,060
+10,000
+6% +$647K 0.18% 130
2022
Q3 		$11.1M Hold
159,060
– – 0.29% 100
2022
Q2 		$10.7M Buy
159,060
+6,000
+4% +$382K 0.26% 115
2022
Q1 		$12.6M Buy
153,060
+63,060
+70% +$6.45M 0.27% 104
2021
Q4 		$13.2M Buy
90,000
+5,780
+7% +$897K 0.29% 99
2021
Q3 		$14.9M Buy
84,220
+13,960
+20% +$2.25M 0.34% 78
2021
Q2 		$11.3M Buy
70,260
+21,900
+45% +$3.52M 0.26% 102
2021
Q1 		$8.28M Buy
48,360
+7,150
+17% +$1.42M 0.23% 120
2020
Q4 		$9.05M Sell
41,210
-17,290
-30% -$3.74M 0.3% 98
2020
Q3 		$9.71M Hold
58,500
– – 0.38% 77
2020
Q2 		$6.68M Buy
58,500
+33,000
+129% +$3.2M 0.27% 102
2020
Q1 		$1.96M Buy
+25,500
New +$2.29M 0.1% 167

Other funds holding MRTX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Edmond de Rothschild Holding's MRTX Position: Q3 2023 in Review

Edmond de Rothschild Holding sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q3 2023, closing a stake of 184,060 shares — an estimated $6.65M sold.

Edmond de Rothschild Holding first reported a position in MRTX in Q1 2020 and held it in 14 quarters. The position peaked at $14.9M in Q3 2021. 213 funds tracked by Wall St. Rank hold MRTX as of Q3 2023.

  • Edmond de Rothschild Holding reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Edmond de Rothschild Holding sold 184,060 Mirati Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $6.65M.
  • Edmond de Rothschild Holding first reported a position in Mirati Therapeutics, Inc. Common Stock in Q1 2020 and held it in 14 quarters.
  • Edmond de Rothschild Holding's Mirati Therapeutics, Inc. Common Stock position peaked at $14.9M in Q3 2021.
  • 213 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Edmond de Rothschild Holding's 13F filing for Q3 2023, filed 13 Nov 2023.